Theravance Biopharma Inc (TBPH)
Change in Working Capital
-$77.75M
Quarterly · Period ending: · USD
TBPH Change in Working Capital
Latest reported-$77.75Mperiod ending
Latest reported-$77.75Mperiod ending
TBPH Quarterly Change in Working Capital (-$266.00K → -$77.75M)
Quarterly change in working capital
High-resolution chart · PNG
TBPH change in working capital history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Change in Working Capital (USD) |
|---|---|
| -77,746,000 | |
| 75,830,000 | |
| 261,670,000 | |
| -16,880,000 | |
| 157,796,000 | |
| 51,937,000 | |
| 13,887,000 | |
| -342,000 | |
| 2,692,000 | |
| 4,118,000 | |
| -3,414,000 | |
| -1,345,000 | |
| -5,870,000 | |
| 2,289,000 | |
| 59,556,000 | |
| -15,226,000 | |
| 1,971,000 | |
| -3,951,000 | |
| -7,516,000 | |
| -7,708,000 | |
| -13,086,000 | |
| -13,108,000 | |
| -14,329,000 | |
| -16,546,000 | |
| -1,150,000 | |
| -7,437,000 | |
| 1,464,000 | |
| -4,580,000 | |
| -12,676,000 | |
| -16,293,000 | |
| -8,434,000 | |
| -691,000 | |
| -32,350,000 | |
| 100,904,000 | |
| 23,799,000 | |
| -14,793,000 | |
| 9,537,000 | |
| 3,888,000 | |
| 27,660,000 | |
| 10,843,000 | |
| 4,623,000 | |
| 3,802,000 | |
| -3,361,000 | |
| 10,328,000 | |
| -14,571,000 | |
| -30,179,000 | |
| 3,572,000 | |
| 8,086,000 | |
| -674,000 | |
| 1,786,000 | |
| 3,039,000 | |
| 1,972,000 | |
| 7,701,000 | |
| -2,536,000 | |
| -1,198,000 | |
| -266,000 |